Skip to content
Nolvadex
Active ingredient: Tamoxifen

Nolvadex

Quality products
24/7 Support
Fast delivery
Delivery from 4 days
Select pack Package Per unit Price

Free delivery on orders from AED 796.00, free express delivery from AED 1,194.00

Secure Payments
Track your order
Best price guarantee

Tamoxifen, a selective estrogen receptor modulator (SERM) and the active ingredient in Nolvadex, is used mainly in hormone-sensitive breast cancer care. It blocks estrogen signalling in breast tissue and is also discussed in off-label post-cycle treatment, where medical assessment is essential.

About this product

Nolvadex contains tamoxifen in tablet form. Tamoxifen belongs to the selective estrogen receptor modulator class, which means it blocks estrogen activity in some tissues while producing estrogen-like effects in others.

Tamoxifen Tablet Composition

The active substance is tamoxifen, supplied as tamoxifen tablets B.P. Tamoxifen citrate is the salt form used in many pharmaceutical products; the body releases tamoxifen from this compound after oral administration.

Dosing differs between strengths and between users, so there is no single amount that suits everyone.

Estrogen Receptor Modulation

A simple way to understand a SERM is to picture a key occupying a receptor lock. Tamoxifen binds to estrogen receptors in breast tissue and reduces the ability of estrogen to stimulate those cells. It does not remove estrogen from the bloodstream or shut down estrogen production throughout the body.

Tamoxifen can act differently in bone, the uterus, the liver, and breast tissue. That tissue-selective behaviour explains both its therapeutic usefulness and its need for medical monitoring.

A new tender lump directly beneath the nipple can have several causes. Do not assume that steroid exposure is responsible before the breast tissue has been examined.

Pharmacological action

Tamoxifen competes with estrogen for receptor binding in breast tissue. When tamoxifen occupies the receptor, estrogen-driven signals are reduced, which can slow stimulation of hormone-sensitive breast cells.

The medicine affects receptor signalling rather than correcting every cause of hormonal imbalance. A symptom can improve while the underlying endocrine problem remains.

What it contains

Nolvadex contains tamoxifen in tablet form. The product presentation is tamoxifen tablets B.P., with 30 tablets per pack. Tamoxifen belongs to the selective estrogen receptor modulator class, which means it blocks estrogen activity in some tissues while producing estrogen-like effects in others.

The approved clinical role of tamoxifen is closely linked to hormone-sensitive Breast Cancer. It is prescribed in situations such as adjuvant treatment after surgery, treatment of advanced disease, and risk reduction for selected patients. The precise indication depends on tumour biology, menopausal status, previous treatment, and the prescribing specialist’s assessment.

Tamoxifen’s early development began in the 1960s, with 1961 often cited in its development history. AstraZeneca later became associated with the commercial history of Nolvadex. The medicine’s clinical value comes from its pharmacology, not from its use in bodybuilding communities.

Tamoxifen Tablet Composition

The active substance is tamoxifen, supplied as tamoxifen tablets B.P. Tamoxifen citrate is the salt form used in many pharmaceutical products; the body releases tamoxifen from this compound after oral administration.

Dosing differs between strengths and between users, so there is no single amount that suits everyone.

Directions for use

The correct tamoxifen dose and treatment duration depend on the diagnosis, age, treatment history, liver function, clotting risk, and interacting medicines. Dosing differs between strengths and between users, so there is no single amount that suits everyone.

For prescribed treatment:

  • Swallow the tablet by mouth with water.
  • Take it at the prescribed time each day.
  • Follow the dose and duration selected for the diagnosed indication.
  • Do not share tablets with another person.
  • Do not create a PCT schedule from an internet forum or bodybuilding routine.
  • If a dose is missed, take it when remembered unless the next dose is close; do not double the dose.
  • Report troublesome visual symptoms, leg swelling, chest pain, or unusual bleeding promptly.

The tablet may be taken with or without food unless the prescriber gives a different instruction. Keeping the daily dose at a consistent time can reduce missed doses, especially during long treatment courses.

Pregnancy avoidance is a major safety issue. Tamoxifen may harm a developing fetus, and fertility planning should be discussed before treatment, including when the intended use is short-term and related to PCT.

A missed dose is not corrected by taking two tablets together. Doubling can increase exposure without improving the treatment outcome.

Reasons not to use it

This medication is not suitable for you if you are pregnant, have a serious tamoxifen allergy, or have a medical situation in which the prescriber has judged the clotting or bleeding risk unacceptable. Patients with a previous deep-vein thrombosis, pulmonary embolism, stroke, clotting disorder, or prolonged immobility need a careful risk review.

Tamoxifen also requires caution in patients with:

  • Liver disease or unexplained abnormal liver tests.
  • A history of retinal or other significant eye disease.
  • Unexplained vaginal bleeding.
  • A personal or family history of clotting disorders.
  • Planned surgery or prolonged bed rest.
  • Fertility goals in the near future.
  • Several hormone-active medicines taken together.

Warfarin and other anticoagulants require specific review because tamoxifen may alter anticoagulant control and bleeding risk. Strong CYP2D6 inhibitors, including some antidepressants, can reduce the formation of active tamoxifen metabolites. Paroxetine and fluoxetine are examples that may require particular attention, although the complete medicine list must be assessed rather than relying on one interaction alone.

When this is not for you

A hard or fixed unilateral mass, nipple discharge, skin retraction, or an armpit lump should prompt prompt medical evaluation. These findings are not typical reasons to begin self-directed PCT.

Tamoxifen should not be treated as a guaranteed hormonal reset. Medical follow-up is needed when PCT is being discussed.

Adverse reactions

Tamoxifen can cause adverse effects ranging from uncomfortable but manageable symptoms to urgent complications. The FDA prescribing information lists vasomotor symptoms, gastrointestinal effects, fatigue, fluid-related symptoms, and thromboembolic risks among the concerns that require patient-specific assessment [1].

Commonly reported effects may include:

  • Hot flashes and sweating.
  • Headache.
  • Nausea or vomiting.
  • Fatigue and weakness.
  • Joint aches or muscle discomfort.
  • Mood changes.
  • Vaginal discharge or bleeding in some patients.
  • Changes in menstrual patterns.
  • Visual disturbances.

Some symptoms overlap with menopause, cancer treatment, hormonal withdrawal, or steroid cessation. A patient should not assume that every headache or period of fatigue is harmless.

Seek urgent medical care for sudden breathlessness, chest pain, coughing blood, one-sided leg swelling, severe leg pain, facial weakness, difficulty speaking, or sudden loss of coordination. These symptoms may indicate venous thrombosis, pulmonary embolism, stroke, or another emergency.

Unusual vaginal bleeding requires medical evaluation, especially after menopause. Tamoxifen has also been associated with endometrial changes, so abnormal bleeding should not be dismissed as a routine side effect.

Visual symptoms deserve attention. Blurred vision, reduced visual acuity, flashes, floaters, or difficulty seeing colours should be reported because tamoxifen can affect the eye in some patients. Liver problems may present with jaundice, dark urine, persistent upper-abdominal discomfort, or unusual itching.

Water retention is not a dependable benefit of tamoxifen. It should not be promoted as a method for preventing fluid accumulation, high blood pressure, or acne. Blood pressure and lipid monitoring may be appropriate when the patient has cardiovascular risk factors, steroid exposure, or prolonged treatment.

Nausea may improve when the tablet is taken with food, provided the prescribed instructions allow this. Persistent vomiting can interfere with treatment and may require a medicine review.

Uses

The approved clinical role of tamoxifen is closely linked to hormone-sensitive Breast Cancer. It is prescribed in situations such as adjuvant treatment after surgery, treatment of advanced disease, and risk reduction for selected patients. The precise indication depends on tumour biology, menopausal status, previous treatment, and the prescribing specialist’s assessment.

Tamoxifen may help some early cases, especially when tenderness and a recent subareolar lump are present. Longstanding fibrotic tissue may not respond fully to medication. Clinical assessment remains important before treatment.

Comparison

Tamoxifen, clomifene, anastrozole, exemestane, and letrozole affect estrogen pathways through different mechanisms. They are not interchangeable, and choosing between them requires a diagnosis, hormone results, medical history, and a review of risks.

Medicine or class Main pharmacological action Clinical considerations
Nolvadex; tamoxifen SERM that blocks estrogen receptors in breast tissue Used in selected hormone-sensitive breast cancer care; clotting, uterine, liver, and visual risks require review
Clomifene; Clomid SERM with different endocrine effects from tamoxifen May be used in selected reproductive or endocrine contexts; visual and mood effects require attention
Anastrozole, exemestane, letrozole Aromatase inhibitors that reduce estrogen production May affect bone density, joint comfort, lipids, and low-estrogen symptoms

Arimidex is associated with anastrozole. Aromasin contains exemestane. Letrozole is also marketed under the name Femara, while some anastrozole products are supplied by different manufacturers, including Accord. These references describe active substances and drug classes, not equivalent treatment choices.

SERMs reduce estrogen signalling at selected receptors. Aromatase inhibitors reduce the conversion of androgens into estrogens. That distinction affects laboratory findings, symptom patterns, bone health, and the risk profile.

A clinician may order hormone tests before selecting a treatment. Taking an aromatase inhibitor after deciding that tamoxifen “is not strong enough” can create excessively low estrogen, joint symptoms, lipid changes, and bone risks.

Common mistakes

Several mistakes lead to poor results or delayed recognition of complications:

  • Starting Nolvadex after steroid use without documenting the substances involved.
  • Treating a 20 mg tablet as a universal daily dose.
  • Confusing reduced breast tenderness with full hormonal recovery.
  • Assuming every enlarged chest is gynecomastia.
  • Doubling the next tablet after a missed dose.
  • Ignoring new floaters, blurred vision, or flashes.
  • Dismissing one-sided leg swelling after starting treatment.
  • Failing to mention antidepressants or anticoagulants.
  • Continuing treatment despite abnormal vaginal bleeding.
  • Using tamoxifen to manage water retention or improve athletic performance.
  • Stopping prescribed breast cancer treatment because symptoms have improved.
  • Taking tamoxifen and an aromatase inhibitor together without a defined clinical reason.

A tender lump under the nipple is not automatically caused by anabolic steroids. A new unilateral lump deserves assessment, especially when it is hard, fixed, rapidly growing, or associated with nipple or skin changes.

PCT recovery should be judged with appropriate follow-up testing, not by mood, libido, erection quality, or the disappearance of nipple sensitivity alone. These symptoms can fluctuate for many reasons.

What doctors say

In clinical practice, doctors usually judge tamoxifen by the condition being treated rather than by the tablet strength alone. A 20 mg presentation may be appropriate for one treatment plan and unsuitable for another, so the indication controls the regimen.

For breast cancer, treatment decisions may involve tumour receptor status, surgery, chemotherapy, radiotherapy, menopausal status, recurrence risk, and previous endocrine therapy. NICE guidance and specialist oncology practice place tamoxifen within a broader treatment plan rather than treating it as a standalone hormone regulator [2].

For gynecomastia, clinicians first look for the cause. A recent painful lump may behave differently from several years of firm tissue. Steroid exposure, liver disease, thyroid disease, obesity, and other medicines can all change the assessment.

For PCT discussions, a doctor would usually separate three questions: what substances were used, what symptoms are present, and whether laboratory tests show endocrine suppression. Symptom relief alone does not establish recovery.

A practical clinical point is easy to miss: fertility planning matters even when the intended course is brief. Tamoxifen changes estrogen-receptor signalling and belongs in a supervised endocrine discussion when conception is a priority.

Questions and answers

Can Nolvadex be combined with antidepressants or anticoagulants?

Tamoxifen can interact with some antidepressants and anticoagulants. Strong CYP2D6 inhibitors such as paroxetine or fluoxetine may reduce the formation of active tamoxifen metabolites, while warfarin can require closer bleeding-risk assessment. The 2023 FDA prescribing information supports a complete interaction review before treatment, and the relevant medicine list should include supplements and anabolic substances [3].

What happens after stopping Nolvadex, and is tapering required?

Tamoxifen is not automatically tapered in every treatment plan. The need for a gradual change depends on the indication, treatment duration, cancer plan, hormonal status, and the prescriber’s decision. Stopping without a plan can interrupt breast cancer treatment or leave post-steroid endocrine problems unassessed; clinical guidance should determine the stopping approach. NICE guidance published in 2025 supports an indication-based review of treatment changes.

How soon can an effect become noticeable?

The timing depends on the condition. Breast tenderness may change before a full assessment of glandular tissue is possible, while endocrine recovery after anabolic steroids cannot be judged from symptoms alone. The FDA prescribing information from 2022 and clinical follow-up support evaluating response over the planned treatment period rather than using an early sensation as proof of recovery.

Which condition rules Nolvadex out completely?

Pregnancy is a clear reason to avoid tamoxifen because fetal harm is possible. A serious allergy to tamoxifen is another direct exclusion, while previous thrombosis, stroke risk, liver disease, and unexplained bleeding require an individual risk decision. The 2023 EMA product information places pregnancy and thromboembolic concerns among the issues requiring careful prescribing review [4].

How long does a Nolvadex course last, and is long-term use acceptable?

Treatment length varies by diagnosis and may extend beyond a short course in breast cancer care. Long-term use can be appropriate when it forms part of an oncology plan, but it brings ongoing considerations involving clotting, uterine symptoms, visual health, liver function, and bone or cardiovascular risk. PCT use does not have the same standardized long-term evidence base as approved cancer treatment, so an online cycle should not define duration. NICE guidance from 2025 supports keeping treatment duration linked to the diagnosed indication.

What should be discussed with a doctor before starting Nolvadex?

Discuss the reason for treatment, pregnancy or fertility plans, past clots or stroke, liver disease, abnormal bleeding, visual symptoms, planned surgery, and every medicine or supplement being taken. Include anabolic steroids and gym products because they can alter hormone results and complicate the risk assessment. MOHAP, EMA, and 2025 NICE oncology guidance all support an indication-based review rather than selecting tamoxifen solely from the tablet strength.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Compare treatments for Oncology

Sources

  1. U.S. Food and Drug Administration (2022). Nolvadex (tamoxifen citrate) tablets, prescribing information.
  2. National Institute for Health and Care Excellence (NICE) (2025). Early and locally advanced breast cancer: diagnosis and management.
  3. U.S. Food and Drug Administration (2023). Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers.
  4. European Medicines Agency (2023). Tamoxifen-containing medicinal products: product information.

Nolvadex: What Customers Say

3.8
Based on 4 reviews
Joel, 27 Madinat Zayed Several weeks
Verified
Rating: 4 out of 5

The tenderness eased during the first few weeks, but I still needed blood tests because I had assumed feeling better meant my hormones were normal. The appointment changed how I viewed PCT.

16 Oct 2026
Waleed, 37 Liwa The first month
Verified
Rating: 4 out of 5

Hot flashes were the main problem. They were irritating at night, and I felt tired after work, but the oncology team adjusted my follow-up rather than telling me to stop on my own.

27 Oct 2026
Bilal, 64 Fujairah The first month
Verified
Rating: 3.5 out of 5

The tablets were easy to swallow, but joint aches and fatigue made the first month difficult. I also had blurred vision once, so I reported it instead of waiting for it to disappear.

6 Nov 2026
Sultan, 33 Abu Dhabi A short period
Verified
Rating: 3.5 out of 5

I expected a short PCT schedule from the internet. The doctor found that the lump needed proper assessment first, and tamoxifen was not started immediately.

14 Nov 2026
Get our free app Shop faster and track your orders 3.8 · 441 reviews Install